CD59 cDNA ORF Clone in Cloning Vector, Human


CD59 cDNA ORF Clone in Cloning Vector, Human: 製品情報

NCBI 参考シーケンス番号
387 bp
Identical with the Gene Bank Ref. ID sequence.
Full length Clone DNA of Human CD59 molecule, complement regulatory protein.
pUC19 Vector
M13-47 and RV-M
The plasmid is confirmed by full-length sequencing.
保存 & 配送
Each tube contains lyophilized plasmid.
The lyophilized plasmid can be stored at ambient temperature for three months.

CD59 cDNA ORF ヌクレオチド配列およびアミノ酸配列に関する情報

**Sino Biological guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories.**

CD59 cDNA ORF Clone in Cloning Vector, Human: 別名

16.3A5 cDNA ORF Clone, Human; 1F5 cDNA ORF Clone, Human; EJ16 cDNA ORF Clone, Human; EJ30 cDNA ORF Clone, Human; EL32 cDNA ORF Clone, Human; FLJ38134 cDNA ORF Clone, Human; FLJ92039 cDNA ORF Clone, Human; G344 cDNA ORF Clone, Human; HRF-20 cDNA ORF Clone, Human; HRF20 cDNA ORF Clone, Human; MAC-IP cDNA ORF Clone, Human; MACIF cDNA ORF Clone, Human; MEM43 cDNA ORF Clone, Human; MGC2354 cDNA ORF Clone, Human; MIC11 cDNA ORF Clone, Human; MIN1 cDNA ORF Clone, Human; MIN2 cDNA ORF Clone, Human; MIN3 cDNA ORF Clone, Human; MIRL cDNA ORF Clone, Human; MSK21 cDNA ORF Clone, Human; p18-20 cDNA ORF Clone, Human

CD59 背景情報

CD59 glycoprotein, also known as 2 kDa homologous restriction factor, HRF2, MAC-inhibitory protein, Membrane attack complex inhibition factor, Membrane inhibitor of reactive lysis, MIC11, MIRL and CD59, is a cell membrane protein which contains one UPAR/Ly6 domain. CD59 is a small, highly glycosylated, GPI-linked protein, with a wide expression profile. The soluble form of CD59 from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes. CD59 is a potent inhibitor of the complement membrane attack complex (MAC) action. CD59 was first identified as a regulator of the terminal pathway of complement. It acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. CD59 is involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. Defects in CD59 are the cause of CD59 deficiency (CD59D).
CD59 molecule
Related Pathways
  • Complement Activation Pathways
    Complement Activation Pathways
  • Fletcher CM. et al., 1994, Structure. 2: 185-99.
  • Rudd PM. et al., 1997, J Biol Chem. 272: 7229-44.
  • Kimberley FC. et al., 2007, Mol Immunol. 44 (1-3): 73-81.
  • Gong Y. et al., 2007, Sci China C Life Sci. 50 (6): 773-9.
  • Picariello G. et al., 2008, Proteomics 8: 3833-47.
  • Heibeck TH. et al., 2009, J Proteome Res. 8: 3852-61.
カートに追加しました カートに追加しませんでした カートを更新しています。少々お待ちください U.S.A.